Optimizing identification of Lyme disease diagnoses in commercial insurance claims data, United States, 2016–2019
Open Access
- 20 November 2024
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 24 (1) , 1-9
Abstract
Background: Commercial insurance claims data are a stable and consistent source of information on Lyme disease diagnoses in the United States and can contribute to our understanding of overall disease burden and the tracking of epidemiological trends. Algorithms consisting of diagnosis codes and antimicrobial treatment information have been used to identify Lyme disease diagnoses in claims data, but there might be opportunity to improve their accuracy. Methods: We developed three modified versions of our existing claims-based Lyme disease algorithm; each reflected refined criteria regarding antimicrobials prescribed and/or maximum days between diagnosis code and qualifying prescription claim. We applied each to a large national commercial claims database to identify Lyme disease diagnoses during 2016–2019. We then compared characteristics of Lyme disease diagnoses identified by each of the modified algorithms to those identified by our original algorithm to assess differences from expected trends in demographics, seasonality, and geography. Results: Observed differences in characteristics of patients with diagnoses identified by the three modified algorithms and our original algorithm were minimal, and differences in age and sex, in particular, were small enough that they could have been due to chance. However, one modified algorithm resulted in proportionally more diagnoses in men, during peak summer months, and in high-incidence jurisdictions, more closely reflecting epidemiological trends documented through public health surveillance. This algorithm limited treatment to only first-line recommended antimicrobials and shortened the timeframe between a Lyme disease diagnosis code and qualifying prescription claim. Conclusions: As compared to our original algorithm, a modified algorithm that limits the antimicrobials prescribed and shortens the timeframe between a diagnosis code and a qualifying prescription claim might more accurately identify Lyme disease diagnoses when utilizing insurance claims data for supplementary, routine identification and monitoring of Lyme disease diagnoses.Keywords
This publication has 26 references indexed in Scilit:
- Claims-Based Diagnostic Patterns of Patients Evaluated for Lyme Disease and Given Extended Antibiotic TherapyVector-Borne and Zoonotic Diseases, 2017
- Lyme Disease Surveillance in New York State: an Assessment of Case UnderreportingZoonoses and Public Health, 2016
- Underreporting of Lyme and Other Tick‐Borne Diseases in Residents of a High‐Incidence County, Minnesota, 2009Zoonoses and Public Health, 2016
- Incidence of Clinician-Diagnosed Lyme Disease, United States, 2005–2010Emerging Infectious Diseases, 2015
- Enhancing Lyme Disease Surveillance by Using Administrative Claims Data, Tennessee, USAEmerging Infectious Diseases, 2015
- Epidemiology of Lyme DiseaseInfectious Disease Clinics of North America, 2015
- Health Care Costs, Utilization and Patterns of Care following Lyme DiseasePLOS ONE, 2015
- Comparing spatio-temporal clusters of arthropod-borne infections using administrative medical claims and state reported surveillance dataSpatial and Spatio-temporal Epidemiology, 2012
- Utility of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Communicable Disease SurveillanceAmerican Journal of Epidemiology, 2010
- The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2006